Trial Profile
Japanese multi institutional study of Primovist-enhanced MRI for non-invasive diagnosis of HCC (JAMP-HCC study)
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 20 May 2016
Price :
$35
*
At a glance
- Drugs Gadoxetate disodium (Primary)
- Indications Liver cancer
- Focus Diagnostic use
- Acronyms JAMP-HCC
- 20 May 2016 New trial record